Access 2.8M+ Filings Sign Up Free
PharmaSGP Holding SE Logo

PharmaSGP Holding SE | PSG - Profile, Filings, Stock Info & Investor Relations Data

PharmaSGP Holding SE | PSG
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Pharmaceuticals
Country
Germany
Founded
2019
PharmaSGP Holding SE (PSG)

Company Profile

Website
Investor Relations

About PharmaSGP Holding SE

harmaSGP is a pharmaceutical company with a broad portfolio of leading, over-the-counter (OTC) drugs and other healthcare products.

Our drugs are based on natural pharmaceutical active ingredients with documented efficacy and have virtually no known side effects. With our pharmacy-exclusive products, we have trusted brands in many relevant chronic indications that are leaders in their respective categories. The herbal-medicine Baldriparan®, is the leading OTC brand in Germany for natural valerian sleep aids. With the brands RubaXX® for rheumatic pain and Restaxil® for neuralgic pain (nerve pain), we are also the market leader for systemic, chemical-free OTC pain relievers.

In addition, the products against sexual weakness, which are marketed under the brands DESEO® and NERADIN®, are the leading chemical-free products in their category in Germany.

Since the launch of the first product from the current portfolio in Germany in 2012, we have successfully exported our business.

Employees

66

Market Presence

Worldwide

Headquarters

Lochhamer Schlag 1
82166, Gräfelfing
Germany

PharmaSGP Holding SE (PSG)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

PharmaSGP Holding SE (PSG)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

↑
FUTRUE GmbH (Close relation)
Buy EUR 12,145,250.00 EUR 24.05 25.11.24
↑
MMI Leisure & Capital Management GmbH (Close relation)
Buy EUR 125,383.20 EUR 26.98 05.10.22
↑
Hillen, Ingo (Board)
Buy EUR 1,048.00 EUR 26.20 05.10.22
↑
MMI Leisure & Capital Management GmbH (Close relation)
Buy EUR 26.60 EUR 26.60 05.10.22
↑
Wittig, Dr. Thomas (Supervisory board)
Buy EUR 138,953.80 EUR 80.13 30.05.22
↑
Schröter, Jasmin (Close relation)
Buy EUR 119,660.00 EUR 1,014.07 30.05.22
↑
Simon-Schröter, Dr. Wolfram (Other)
Buy EUR 10,040.00 EUR 1,004.00 30.05.22
↑
FUTRUE GmbH (Close relation)
Buy EUR 208,180.53 EUR 23.13 25.04.22
↓
MMI Leisure & Capital Management GmbH (Close relation)
Sell EUR 197,193.60 EUR 98.40 25.04.22
↓
Bloching, Prof. Dr. Micha (Supervisory board)
Sell EUR 171,825.00 EUR 22.91 25.04.22

PharmaSGP Holding SE (PSG)
Stock & Investor Information

ISINs

DE000A2P4LJ5

LEI

3912005CZ12PVVCIPT91

Designated Sponsor

Joh. Berenberg, Gossler & Co. KG

Stock Exchange Listings

Frankfurt Stock Exchange

Industry Classification

Sector
Health Care
Industry
Pharmaceuticals